Anna Berkenblit
2017
In 2017, Anna Berkenblit earned a total compensation of $998.9K as Senior Vice President and Chief Medical Officer at ImmunoGen.
Compensation breakdown
| Non-Equity Incentive Plan | $193,029 |
|---|---|
| Salary | $408,526 |
| Stock Awards | $388,531 |
| Other | $8,784 |
| Total | $998,870 |
Berkenblit received $408.5K in salary, accounting for 41% of the total pay in 2017.
Berkenblit also received $193K in non-equity incentive plan, $388.5K in stock awards and $8.8K in other compensation.
Rankings
In 2017, Anna Berkenblit's compensation ranked 8,979th out of 14,666 executives tracked by ExecPay. In other words, Berkenblit earned more than 38.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,979 out of 14,666 | 39th |
Division Manufacturing | 3,437 out of 5,772 | 41st |
Major group Chemicals And Allied Products | 1,173 out of 2,075 | 44th |
Industry group Drugs | 937 out of 1,731 | 46th |
Industry Pharmaceutical Preparations | 735 out of 1,333 | 45th |
Source: SEC filing on April 28, 2020.
Berkenblit's colleagues
We found four more compensation records of executives who worked with Anna Berkenblit at ImmunoGen in 2017.